Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and ethylenediamine

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with ethylenediamine in 2 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Studies
(ethylenediamine)
Trials
(ethylenediamine)
Recent Studies (post-2010) (ethylenediamine)
638312438706308

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lei, H; Li, X; Pei, F; Wang, X; Xiao, Y; Xue, R; You, T1
Li, X; Pei, F; Xiao, Y; Xue, R; You, T1

Other Studies

2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and ethylenediamine

ArticleYear
Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.
    Carbohydrate research, 2014, Aug-18, Volume: 395

    Topics: Animals; Cell Survival; Contrast Media; Ethylenediamines; Galactans; Glycoconjugates; Hepatocytes; Heterocyclic Compounds; Humans; Injections, Intravenous; Liver; Magnetic Resonance Imaging; Male; Organometallic Compounds; Rats; Rats, Wistar

2014
A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent.
    Magnetic resonance imaging, 2015, Volume: 33, Issue:6

    Topics: Animals; Contrast Media; Ethylenediamines; Heterocyclic Compounds; Humans; Liver; Magnetic Resonance Imaging; Mice; Organometallic Compounds; Polymers; Rats; Rats, Wistar; Reference Values

2015